Corbus Pharmaceuticals Holding (CRBP) Insider Trading
- $42,913,851.27
- $3,500,316.12
- Sept. 20, 2024
- Sean F Moran
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 10, 2017 | CEO | 1,000 | $7.17 | Buy | $7,170.00 | |
Nov. 10, 2017 | Director | 10,000 | $7.08 | Buy | $70,800.00 | |
Aug. 11, 2017 | Insider | 2,479 | $6.05 | Buy | $14,997.95 | |
Aug. 11, 2017 | CFO | 2,500 | $5.91 | Buy | $14,775.00 | |
Aug. 11, 2017 | CEO | 1,695 | $6.00 | Buy | $10,170.00 | |
May 11, 2017 | CFO | 3,300 | $6.14 | Buy | $20,262.00 | |
May 11, 2017 | Insider | 2,435 | $6.12 | Buy | $14,902.20 | |
May 11, 2017 | Director | 3,400 | $6.18 | Buy | $21,012.00 | |
May 11, 2017 | CEO | 3,250 | $6.01 | Buy | $19,532.50 | |
March 17, 2017 | Insider | 4,233 | $9.49 | Buy | $40,171.17 | |
March 13, 2017 | CFO | 2,000 | $9.60 | Buy | $19,200.00 | |
Dec. 2, 2016 | CFO | 1,500 | $7.20 | Buy | $10,800.00 | |
Nov. 22, 2016 | CEO | 1,340 | $7.64 | Buy | $10,237.60 | |
Nov. 22, 2016 | Director | 1,000 | $7.49 | Buy | $7,490.00 | |
Nov. 18, 2016 | Director | 10,000 | $7.00 | Buy | $70,000.00 | |
Sept. 8, 2016 | CFO | 30,800 | $5.12 | Buy | $157,696.00 | |
Aug. 26, 2016 | CFO | 17,900 | $3.92 | Buy | $70,168.00 | |
Aug. 22, 2016 | Director | 1,800 | $3.77 | Buy | $6,786.00 | |
Aug. 18, 2016 | CFO | 148,960 | $3.32 | Buy | $494,547.20 | |
Aug. 17, 2016 | Insider | 38,000 | $3.15 | Buy | $119,700.00 | |
June 8, 2016 | Insider | 1,935 | $3.10 | Buy | $5,998.50 | |
June 6, 2016 | CEO | 1,500 | $3.34 | Buy | $5,010.00 | |
June 1, 2016 | Insider | 2,570 | $3.52 | Buy | $9,046.40 | |
May 19, 2016 | CFO | 27,250 | $2.37 | Buy | $64,582.50 | |
May 18, 2016 | CEO | 2,125 | $2.40 | Buy | $5,100.00 | |
May 18, 2016 | CFO | 30,000 | $2.39 | Buy | $71,700.00 | |
Dec. 11, 2015 | CFO | 1,000 | $1.56 | Buy | $1,560.00 | |
Dec. 10, 2015 | CFO | 1,000 | $1.61 | Buy | $1,610.00 | |
Dec. 9, 2015 | CFO | 1,000 | $1.67 | Buy | $1,670.00 | |
Dec. 8, 2015 | CFO | 1,000 | $1.68 | Buy | $1,680.00 | |
Dec. 7, 2015 | CFO | 1,000 | $1.69 | Buy | $1,690.00 | |
Dec. 4, 2015 | CFO | 1,000 | $1.72 | Buy | $1,720.00 | |
Dec. 2, 2015 | CFO | 1,000 | $1.79 | Buy | $1,790.00 | |
Nov. 24, 2015 | CFO | 1,500 | $1.78 | Buy | $2,670.00 | |
Nov. 20, 2015 | CFO | 1,500 | $1.70 | Buy | $2,550.00 | |
Nov. 19, 2015 | Insider | 4,000 | $1.67 | Buy | $6,680.00 | |
Nov. 18, 2015 | CFO | 1,500 | $1.71 | Buy | $2,565.00 | |
Nov. 17, 2015 | CFO | 1,500 | $1.72 | Buy | $2,580.00 | |
Nov. 16, 2015 | CFO | 2,000 | $1.69 | Buy | $3,380.00 | |
Sept. 16, 2015 | CFO | 5,000 | $2.12 | Buy | $10,600.00 | |
Sept. 15, 2015 | CFO | 5,000 | $2.14 | Buy | $10,700.00 | |
Sept. 14, 2015 | CFO | 5,000 | $1.96 | Buy | $9,800.00 | |
Sept. 11, 2015 | CFO | 5,000 | $1.85 | Buy | $9,250.00 | |
Sept. 3, 2015 | Insider | 10,000 | $1.84 | Buy | $18,400.00 | |
Aug. 25, 2015 | Insider | 6,000 | $1.87 | Buy | $11,220.00 | |
Aug. 21, 2015 | Insider | 10,000 | $2.05 | Buy | $20,500.00 | |
Aug. 21, 2015 | CFO | 1,400 | $2.06 | Buy | $2,884.00 | |
Aug. 19, 2015 | Major Shareholder | 200,000 | $3.04 | Sell | $608,000.00 | |
Aug. 18, 2015 | Director | 10,000 | $1.89 | Buy | $18,900.00 | |
Aug. 18, 2015 | insider | 20,000 | $1.90 | Buy | $38,000.00 |
Insiders are both buying and selling Corbus Pharmaceuticals Holding stock.
The insider traders at Corbus Pharmaceuticals Holding are: Sean F Moran, Barbara White, Yuval Cohen, David P Hochman, Craig Stuart Millian, Cormorant Asset Management, Lp, Robert Paul Discordia, Avery W Catlin, Sumner Burstein, John Kenneth Jenkins, Alan F Holmer, Mark Tepper, and Renu Gupta
The most active insider trader at Corbus Pharmaceuticals Holding is Sean F Moran with 49 trades.
Yuval Cohen has sold the most Corbus Pharmaceuticals Holding stock with a total value of $2,492,754.01.
Cormorant Asset Management, Lp has bought the most Corbus Pharmaceuticals Holding stock with a total value of $47,381,555.68.
The most recent insider trade for Corbus Pharmaceuticals Holding was on Sept. 20, 2024.
The single biggest insider buy for Corbus Pharmaceuticals Holding was from Cormorant Asset Management, Lp with a total value of $14,250,000.00 on Feb. 2, 2024.
The single biggest insider sell for Corbus Pharmaceuticals Holding was from Yuval Cohen with a total value of $1,470,833.89 on June 14, 2024.